Muromonab-CD3 FDA Link

Anti-CD3 monoclonal antibody that exerts immunosuppressive effects by inducing peripheral T-cell depletion and modulation of the T-cell receptor complex (CD3/Ti).

Also Known As:

Muromonab CD3; OKT3; Orthoclone OKT3; Monoclonal Antibody OKT3

Pharmalogical Action Categories:

Immunologic Factors
Immunosuppressive Agents

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Murine-Derived Monoclonal Antibodies: 1
        Muromonab-CD3: 726
        Immunoglobulin Isotypes: 1085
        Immunoglobulin G: 58863
        Muromonab-CD3: 726
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Murine-Derived Monoclonal Antibodies: 1
        Muromonab-CD3: 726
        Immunoglobulin Isotypes: 1085
        Immunoglobulin G: 58863
        Muromonab-CD3: 726
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Murine-Derived Monoclonal Antibodies: 1
        Muromonab-CD3: 726
        Immunoglobulin Isotypes: 1085
        Immunoglobulin G: 58863
        Muromonab-CD3: 726

F P P Martins Selected Research

F P P Martins Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure